AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Apriglim-M 0.5 Tablet PR

Prescription Icon
Prescription Required

Marketer

Aprica Pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (0.5mg) + Metformin (500mg)

Overview Apriglim-M 0.5 Tablet PR

Diabetace-M 0.5mg tablets are classified as anti-diabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer Diabetace-M 0.5mg with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with well-controlled blood sugar, as premature discontinuation without medical consultation risks elevated glucose levels and potential complications like kidney impairment, vision loss, neuropathy, and limb amputation. This medication complements a holistic diabetes management plan, incorporating a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse effect, characterized by sweating, dizziness, headache, and tremors. Prevent this by maintaining regular mealtimes and carrying readily-available glucose sources (e.g., sugary snacks, juice). Alcohol consumption elevates hypoglycemia risk and should be avoided. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. Diabetace-M 0.5mg is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals must consult their doctor before use. Regular blood glucose monitoring is essential, along with periodic blood tests to assess blood cell counts and liver function.

Uses of Apriglim-M 0.5 Tablet PR

Managing type 2 diabetes

Major Benefits of Apriglim-M 0.5 Tablet PR:

Follow your doctor's instructions or consult the product label for dosage information. Consume Apriglim-M 0.5mg Tablet PR with food.

Common Side effects of Apriglim-M 0.5 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Apriglim-M 0.5 Tablet PR:

Follow your doctor's instructions or consult the product information leaflet for usage guidance. Take Apriglim-M 0.5mg Tablet PR with a meal.

How Apriglim-M 0.5 Tablet PR works:

Apriglim-M 0.5 PR tablets contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Apriglim-M 0.5 Tablet PR and alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Apriglim-M 0.5 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation is contraindicated for patients using Apriglim-M 0.5 mg tablets. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when administering Apriglim-M 0.5 Tablet PR to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Apriglim-M 0.5 Tablet PR is contraindicated in patients exhibiting severe kidney disease. Close monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Apriglim-M 0.5 Tablet PR cautiously, potentially requiring dosage modification. Consult a physician before use. A reduced initial dose is typically prescribed for individuals with mild to moderate liver disease; however, Apriglim-M 0.5 Tablet PR is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Apriglim-M 0.5 Tablet PR :

Should you forget a dose of Apriglim-M 0.5mg Tablet PR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Apriglim-M 0.5 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Apriglim-M 0.5 Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Apriglim-M 0.5 Tablet PR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Apriglim-M 0.5 Tablet PR and seek immediate medical attention.
Apriglim-M 0.5 Tablet PR combines glimepiride and metformin to treat type 2 diabetes mellitus (DM) in adults. It enhances blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 DM.
Apriglim-M 0.5 Tablet PR may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Prolonged Apriglim-M 0.5 Tablet PR use can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may cause anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate these risks, annual supplemental Vitamin B12 is recommended by some researchers.
Apriglim-M 0.5 Tablet PR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Apriglim-M 0.5 Tablet PR with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Apriglim-M 0.5 Tablet PR
95
MRP 110
13% off